ACTRN12611000937910已完成未知
Irreversible Electroporation (IRE) for the treatment focal liver, kidney and lung cancer ablation: a pilot study
The Alfred Hospital0 个研究点目标入组 40 人开始时间: 2011年8月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 35 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Ages 35-85 years, Signed informed consent, Failed conventional treatment, Ability to visualize cancer foci adequately on imaging.
排除标准
- •Patients not deemed suitable for ablation procedure.
研究者
相似试验
招募中
2 期
Irreversible Electroporation for treatment of unresectable, locally advanced pancreatic cancer in the Leiden University Medical Centre: a phase I/II study.pancreatic cancercarcinoma of the pancreas1001981510019818NL-OMON40396eids Universitair Medisch Centrum15
尚未招募
不适用
Irreversible Electroporation for treatment of unresectable, locally advanced pancreatic cancer in the Leiden University Medical Center: a phase I/II studyocally advanced unresectable pancreatic cancer, alvleesklierkanker, lokaal uitgebreidNL-OMON21164eiden University Medical Centre15
进行中（未招募）
1 期
Irreversible electroporation (NanoKnife) in combination with immunotherapy for non-curable pancreatic cancerPatients with non-curable pancreatic cancerMedDRA version: 20.0Level: LLTClassification code 10033575Term: Pancreas cancerSystem Organ Class: 100000004864EUCTR2020-004623-17-DKZealand University Hospital12
招募中
不适用
Efficacy of IRE for patients with HCCHepatocellular carcinomaJPRN-jRCTs032190083Sugimoto Katsutoshi45
招募中
不适用
A pilot study evaluating focal irreversible electroporation as treatment for participants with recurrent prostate cancer after radiotherapy.Recurrent Prostate CancerACTRN12617000806369St. Vincent’s Private Hospital10